Previously Treated Non-Small Cell Lung Cancer
Oncology
Prevalence
75.0 / 100K
Incidence
47.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| screening platform | GH Research PLC (GHRS) |
Frequently asked questions
How many drugs are in development for Previously Treated Non-Small Cell Lung Cancer?
BioSniper tracks 1 drug in development for Previously Treated Non-Small Cell Lung Cancer across 1 company.
How many clinical trials target Previously Treated Non-Small Cell Lung Cancer?
There are 1 clinical trial targeting Previously Treated Non-Small Cell Lung Cancer tracked by BioSniper.
What is the prevalence of Previously Treated Non-Small Cell Lung Cancer?
The estimated prevalence of Previously Treated Non-Small Cell Lung Cancer is approximately 75.0 per 100,000 population.
Deep-dive into Previously Treated Non-Small Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis